Thymic Epithelial Tumor Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Thymic Epithelial Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

Non-small Cell Lung CancerSmall Cell Lung CancerExtrapulmonary Small Cell Cancer+2 more
National Cancer Institute (NCI)2,000 enrolled1 locationNCT02146170
Recruiting
Phase 2

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Thymic Epithelial TumorThymic CancerRecurrent Thymoma
National Cancer Institute (NCI)53 enrolled1 locationNCT05104736
Recruiting

Molecular Analysis and Treatment Options of Thymic Malignancies

Thymic CarcinomaThymic Epithelial TumorThymic Cancer
Shanghai Chest Hospital500 enrolled1 locationNCT05667948
Recruiting
Not Applicable

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

ThymomaThymic Epithelial TumorThymoma and Thymic Carcinoma+1 more
Rongrong Zhou100 enrolled1 locationNCT06692062
Recruiting

Establishing Prospective Mediastinal Tumor Database of PUMCH

Germ Cell TumorLymphomaThymic Epithelial Tumor+4 more
Peking Union Medical College Hospital2,000 enrolled1 locationNCT06421805
Recruiting

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

ThymomaThymic CarcinomaThymic Epithelial Tumor+1 more
Erasmus Medical Center1,020 enrolled1 locationNCT06301945
Recruiting

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

Esophageal Squamous Cell CarcinomaNSCLCThymic Epithelial Tumor
Shanghai Cancer Hospital, China500 enrolled1 locationNCT04522687